🔎 Trials Near Me

Akèy › Limfòm selil B › Pennsylvania › Philadelphia

Etid klinik pou Limfòm selil B nan Philadelphia, PA

11 etid pou Limfòm selil B ap chèche patisipan nan sit nan ak bò kote Philadelphia (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.

Tèks ofisyèl etid la (Anglè)

Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →

Pharmacokinetic Study of Venetoclax Tablets Crushed and Dissolved Into a Solution

Ap rekriteEtid obsèvasyon
  • Children's Hospital of Philadelphia, Philadelphia
Laj 0 a 38 · Tout sèks · Mizajou Oct 1, 2026 · NCT06131801

A Study of LY4152199 in Participants With Previously Treated B-cell Malignancies (BAF_FRontier-1 )

Ap rekriteFaz 1
  • University of Pennsylvania Abramson Cancer Center, Philadelphia
Laj 18 ak plis · Tout sèks · Mizajou Sep 22, 2026 · NCT07101328

Surovatamig (AZD0486) as Monotherapy in Participants With Relapsed/Refractory (R/R) B-cell NHL

Ap rekriteFaz 2
  • Research Site, Philadelphia
Laj 18 ak plis · Tout sèks · Mizajou Sep 11, 2026 · NCT06526793

A Study to Investigate Safety and Effectiveness of Tacabrutideg (BGB-16673) in Combination With Other Agents in Participants With Relapsed or Refractory B-Cell Malignancies

Ap rekriteFaz 1/2
  • Fox Chase Cancer Center, Philadelphia
Laj 18 ak plis · Tout sèks · Mizajou Sep 11, 2026 · NCT06634589

A Study of AZD0486 Monotherapy or in Combination With Other Anti-Cancer Agents for Mature B-Cell Malignancies

Ap rekriteFaz 1/2
  • Research Site, Philadelphia
Laj 18 ak plis · Tout sèks · Mizajou Sep 8, 2026 · NCT06564038

Study of Rondecabtagene Autoleucel in Aggressive Large B-Cell Lymphoma

Ap rekriteFaz 1/2
  • Thomas Jefferson University, Philadelphia
Laj 18 ak plis · Tout sèks · Mizajou Aug 25, 2026 · NCT05826535

A Study of Tulmimetostat DZR123 (CPI-0209) in Patients With Advanced Solid Tumors and Lymphomas

Ap rekriteFaz 1/2
  • Abramson Cancer Center of the University of Pennsylvania, Philadelphia
Laj 18 ak plis · Tout sèks · Mizajou Aug 19, 2026 · NCT04104776

CD45BE-HSPC + CART-45 Cells

Ap rekriteFaz 1
  • University of Pennsylvania, Philadelphia
Laj 18 ak plis · Tout sèks · Mizajou Aug 10, 2026 · NCT07451054

SynKIR-310 for Relapsed/Refractory B-NHL

Ap rekriteFaz 1
  • Abramson Cancer Center of the University of Pennsylvania, Philadelphia
Laj 18 ak plis · Tout sèks · Mizajou Apr 14, 2026 · NCT06544265

Tagraxofusp in Pediatric Patients With Relapsed or Refractory CD123 Expressing Hematologic Malignancies

Ap rekriteFaz 1
  • Children's Hospital of Philadelphia, Philadelphia
Laj 1 a 21 · Tout sèks · Mizajou Dec 6, 2024 · NCT05476770

Etid Limfòm selil B nan lòt vil

Lòt etid nan Philadelphia

Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.